US-based research management organisation Pharmatech Oncology has launched a data management business unit that will maintain and process data for a broad range of clinical trials extending beyond the company’s core expertise in oncology and haematology.
Branded as C(3)DM (Customised, Consistent and Clinical Data Management), the new unit uses a system platform based around OmniComm Systems’ TrialMaster electronic data capture solution. The platform can be customised to incorporate full clinical data elements of individual clinical trials, Pharmatech said.
“Our unique platform gives clients access to a wide range of capabilities by having their data managed through a trusted and reliable source, while also having our clinical sites trained by the creators of the system,” commented clinical data manager Jason Lones.
In January Pharmatech launched a campaign highlighting its focus on oncology clinical trials. Part of that initiative was to operate in future under the subsidiary name of Pharmatech Oncology.
Pharmatech was set up in 1987 with the aim of becoming the first ever research management organisation, a concept that brings together the functions of a site management organisation and a contract research organisation.
Headquartered in Denver, Colorado, the company runs an oncology network covering around 200 investigative sites and 1,400 community-based oncologists.
TrialMaster is OmniComm’s flagship technology, a web-based software system that enables clinical trial sponsors and investigative sites to collect, validate, transmit and analyse clinical study data. OmniComm operates out of Fort Lauderdale, Florida.
